|
|
|
|
|
| (11) | Liudijimo numeris | C 3044231 |
| (68) | Patento numeris | 3044231 |
| (21) | Paraiškos papildomos apsaugos liudijimui gauti numeris | PA 2023 508 |
| (22) | Paraiškos papildomos apsaugos liudijimui gauti padavimo data | 2023-02-20 |
| (41) | Paraiškos papildomos apsaugos liudijimui gauti paskelbimo data | 2023-04-11 |
| Liudijimo paskelbimo data | 2025-04-10 | |
| (24) | Liudijimo įsigaliojimo data | 2034-09-11 |
| (71) |
BioMarin Pharmaceutical Inc. ,
105 Digital Drive, Novato, CA 94949,
US
University College London , Gower Street, London WC1E 6BT, GB St. Jude Children's Research Hospital , 262 Danny Thomas Place, Memphis, TN 38105-3678, US |
| (73) |
BioMarin Pharmaceutical Inc. ,
105 Digital Drive, Novato, CA 94949,
US
University College London , Gower Street, London WC1E 6BT, GB St. Jude Children's Research Hospital , 262 Danny Thomas Place, Memphis, TN 38105-3678, US |
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (93) | EU/1/22/1668, 2022-08-24 |
| (94) | 2037-08-25 |
| (95) | Valoktokogeno roksaparvovekas visose pagrindiniu patentu apsaugotose formose |
| PAL išduotas |